Submitted by Anonymous (not verified) on 25 September 2023 - 7:42
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Dementia;Alzheimer Disease;Parkinson Disease, Date of authorisation: 10/12/2009, Revision: 14, Status: Authorised
Source: